- Home
- WHLR vs INM Comparison
WHLR vs INM Comparison
Compare WHLR & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- INM
- Stock Information
- Founded
- WHLR 2011
- INM 1981
- Country
- WHLR United States
- INM Canada
- Employees
- WHLR N/A
- INM N/A
- Industry
- WHLR Real Estate Investment Trusts
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- INM Health Care
- Exchange
- WHLR Nasdaq
- INM Nasdaq
- Market Cap
- WHLR 4.2M
- INM 4.3M
- IPO Year
- WHLR 2012
- INM N/A
- Fundamental
- Price
- WHLR $2.30
- INM $2.32
- Analyst Decision
- WHLR
- INM
- Analyst Count
- WHLR 0
- INM 0
- Target Price
- WHLR N/A
- INM N/A
- AVG Volume (30 Days)
- WHLR 4.5M
- INM 44.9K
- Earning Date
- WHLR 11-06-2025
- INM 11-13-2025
- Dividend Yield
- WHLR N/A
- INM N/A
- EPS Growth
- WHLR N/A
- INM N/A
- EPS
- WHLR N/A
- INM N/A
- Revenue
- WHLR $102,799,000.00
- INM $4,920,990.00
- Revenue This Year
- WHLR N/A
- INM N/A
- Revenue Next Year
- WHLR N/A
- INM N/A
- P/E Ratio
- WHLR N/A
- INM N/A
- Revenue Growth
- WHLR N/A
- INM N/A
- 52 Week Low
- WHLR $1.50
- INM $1.72
- 52 Week High
- WHLR $8,593.20
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- WHLR 51.46
- INM 54.40
- Support Level
- WHLR N/A
- INM $2.11
- Resistance Level
- WHLR $2.59
- INM $2.28
- Average True Range (ATR)
- WHLR 0.29
- INM 0.10
- MACD
- WHLR 0.08
- INM 0.03
- Stochastic Oscillator
- WHLR 88.80
- INM 87.35
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.